Marshall Wace »

Atrium Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2026-03-31 $450k 34k 13.37

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Spdr Portfolio L Etp (SPYM)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Adv Micro Device Equity Option Call Option (AMD)
Alphabet Inc-a Common Stock (GOOGL)
Chevron Corp Common Stock (CVX)
Taiwan Semic- Adr (TSM)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
Hilton Worldwide Common Stock (HLT)
Morgan Stanley Common Stock (MS)
Alphabet Inc-c Common Stock (GOOG)

View all positions for Marshall Wace

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics